First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx)

J. Holt Rose, Amos Norman, Marylou Ingram, Chuck Aoki, Tim Solberg, Albert Mesa

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Purpose: This Phase I study was designed to evaluate the computed tomography (CT) scanner as a device for radiation therapy of human brain tumors (CTRx). This first use in humans of a modified CT for treatment was founded on extensive research experience with canine tumors. An additional objective was to increase the therapeutic radiation dose to tumors compared to normal tissue by concentration of infused contrast material in tumors, an effect available at diagnostic x-ray energies but not at megavoltage energies. Methods and Materials: A small metastatic brain tumor in each of eight patients received 3-5-weekly fractions of 5 Gy equivalent per fraction from a CT scanner modified to deliver radiation therapy. In each patient, one additional tumor, lying completely outside the volume treated by CTRx, served as a control. The tumor receiving CTRx was treated after infusion of iodinated x-ray contrast media (CM) for dose enhancement. Many of these patients also received conventional 40 Gy whole brain radiation, before, during, or after CTRx treatment. Results: None of the patients showed adverse reactions to the CM or necrosis of the normal brain from the CTRx boost radiation. Monte Carlo calculations of the radiation dose distributions in a model tumor showed that the CTRx irradiation of tumors carrying 10 mg or more of iodine per gram of tumor was as good or better than the dose distribution from conventional 10-MV X-rays. The treated tumor in two of the patients vanished after four treatments, whereas a control tumor in one patient remained constant and grew 4-fold in another patient. Conclusion: The CTRx concept effectively combines a modified CT scanner as a diagnostic device, as a simulator dedicated to radiotherapy, and as a treatment machine. Thus, CTRx could be very useful for radiation oncologists in controlling CM-enhanced and other small brain tumors.

Original languageEnglish (US)
Pages (from-to)1127-1132
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume45
Issue number5
DOIs
StatePublished - Dec 1 1999

Fingerprint

Brain Neoplasms
scanners
brain
radiation therapy
Radiotherapy
tumors
tomography
Tomography
X-Ray Computed Tomography Scanners
Neoplasms
Contrast Media
Radiation
X-Rays
radiation
dosage
Therapeutics
Equipment and Supplies
Brain
Iodine
x rays

Keywords

  • Brain radiotherapy
  • CT
  • Radiation dose enhancement
  • Radiosurgery
  • Stereotactic techniques

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx). / Rose, J. Holt; Norman, Amos; Ingram, Marylou; Aoki, Chuck; Solberg, Tim; Mesa, Albert.

In: International Journal of Radiation Oncology Biology Physics, Vol. 45, No. 5, 01.12.1999, p. 1127-1132.

Research output: Contribution to journalArticle

Rose, J. Holt ; Norman, Amos ; Ingram, Marylou ; Aoki, Chuck ; Solberg, Tim ; Mesa, Albert. / First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx). In: International Journal of Radiation Oncology Biology Physics. 1999 ; Vol. 45, No. 5. pp. 1127-1132.
@article{c44cea8ae31543c7809427d9bc910110,
title = "First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx)",
abstract = "Purpose: This Phase I study was designed to evaluate the computed tomography (CT) scanner as a device for radiation therapy of human brain tumors (CTRx). This first use in humans of a modified CT for treatment was founded on extensive research experience with canine tumors. An additional objective was to increase the therapeutic radiation dose to tumors compared to normal tissue by concentration of infused contrast material in tumors, an effect available at diagnostic x-ray energies but not at megavoltage energies. Methods and Materials: A small metastatic brain tumor in each of eight patients received 3-5-weekly fractions of 5 Gy equivalent per fraction from a CT scanner modified to deliver radiation therapy. In each patient, one additional tumor, lying completely outside the volume treated by CTRx, served as a control. The tumor receiving CTRx was treated after infusion of iodinated x-ray contrast media (CM) for dose enhancement. Many of these patients also received conventional 40 Gy whole brain radiation, before, during, or after CTRx treatment. Results: None of the patients showed adverse reactions to the CM or necrosis of the normal brain from the CTRx boost radiation. Monte Carlo calculations of the radiation dose distributions in a model tumor showed that the CTRx irradiation of tumors carrying 10 mg or more of iodine per gram of tumor was as good or better than the dose distribution from conventional 10-MV X-rays. The treated tumor in two of the patients vanished after four treatments, whereas a control tumor in one patient remained constant and grew 4-fold in another patient. Conclusion: The CTRx concept effectively combines a modified CT scanner as a diagnostic device, as a simulator dedicated to radiotherapy, and as a treatment machine. Thus, CTRx could be very useful for radiation oncologists in controlling CM-enhanced and other small brain tumors.",
keywords = "Brain radiotherapy, CT, Radiation dose enhancement, Radiosurgery, Stereotactic techniques",
author = "Rose, {J. Holt} and Amos Norman and Marylou Ingram and Chuck Aoki and Tim Solberg and Albert Mesa",
year = "1999",
month = "12",
day = "1",
doi = "10.1016/S0360-3016(99)00347-8",
language = "English (US)",
volume = "45",
pages = "1127--1132",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx)

AU - Rose, J. Holt

AU - Norman, Amos

AU - Ingram, Marylou

AU - Aoki, Chuck

AU - Solberg, Tim

AU - Mesa, Albert

PY - 1999/12/1

Y1 - 1999/12/1

N2 - Purpose: This Phase I study was designed to evaluate the computed tomography (CT) scanner as a device for radiation therapy of human brain tumors (CTRx). This first use in humans of a modified CT for treatment was founded on extensive research experience with canine tumors. An additional objective was to increase the therapeutic radiation dose to tumors compared to normal tissue by concentration of infused contrast material in tumors, an effect available at diagnostic x-ray energies but not at megavoltage energies. Methods and Materials: A small metastatic brain tumor in each of eight patients received 3-5-weekly fractions of 5 Gy equivalent per fraction from a CT scanner modified to deliver radiation therapy. In each patient, one additional tumor, lying completely outside the volume treated by CTRx, served as a control. The tumor receiving CTRx was treated after infusion of iodinated x-ray contrast media (CM) for dose enhancement. Many of these patients also received conventional 40 Gy whole brain radiation, before, during, or after CTRx treatment. Results: None of the patients showed adverse reactions to the CM or necrosis of the normal brain from the CTRx boost radiation. Monte Carlo calculations of the radiation dose distributions in a model tumor showed that the CTRx irradiation of tumors carrying 10 mg or more of iodine per gram of tumor was as good or better than the dose distribution from conventional 10-MV X-rays. The treated tumor in two of the patients vanished after four treatments, whereas a control tumor in one patient remained constant and grew 4-fold in another patient. Conclusion: The CTRx concept effectively combines a modified CT scanner as a diagnostic device, as a simulator dedicated to radiotherapy, and as a treatment machine. Thus, CTRx could be very useful for radiation oncologists in controlling CM-enhanced and other small brain tumors.

AB - Purpose: This Phase I study was designed to evaluate the computed tomography (CT) scanner as a device for radiation therapy of human brain tumors (CTRx). This first use in humans of a modified CT for treatment was founded on extensive research experience with canine tumors. An additional objective was to increase the therapeutic radiation dose to tumors compared to normal tissue by concentration of infused contrast material in tumors, an effect available at diagnostic x-ray energies but not at megavoltage energies. Methods and Materials: A small metastatic brain tumor in each of eight patients received 3-5-weekly fractions of 5 Gy equivalent per fraction from a CT scanner modified to deliver radiation therapy. In each patient, one additional tumor, lying completely outside the volume treated by CTRx, served as a control. The tumor receiving CTRx was treated after infusion of iodinated x-ray contrast media (CM) for dose enhancement. Many of these patients also received conventional 40 Gy whole brain radiation, before, during, or after CTRx treatment. Results: None of the patients showed adverse reactions to the CM or necrosis of the normal brain from the CTRx boost radiation. Monte Carlo calculations of the radiation dose distributions in a model tumor showed that the CTRx irradiation of tumors carrying 10 mg or more of iodine per gram of tumor was as good or better than the dose distribution from conventional 10-MV X-rays. The treated tumor in two of the patients vanished after four treatments, whereas a control tumor in one patient remained constant and grew 4-fold in another patient. Conclusion: The CTRx concept effectively combines a modified CT scanner as a diagnostic device, as a simulator dedicated to radiotherapy, and as a treatment machine. Thus, CTRx could be very useful for radiation oncologists in controlling CM-enhanced and other small brain tumors.

KW - Brain radiotherapy

KW - CT

KW - Radiation dose enhancement

KW - Radiosurgery

KW - Stereotactic techniques

UR - http://www.scopus.com/inward/record.url?scp=0032777396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032777396&partnerID=8YFLogxK

U2 - 10.1016/S0360-3016(99)00347-8

DO - 10.1016/S0360-3016(99)00347-8

M3 - Article

VL - 45

SP - 1127

EP - 1132

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 5

ER -